Form 4: Jaguar Health Director Anula Jayasuriya Receives Equity Grants

Jaguar Health, Inc. Director Anula Jayasuriya was granted 5,870 restricted stock units and 5,870 stock options on December 11, 2025, as reported in a Form 4 filing.

Summary

• Director Anula Jayasuriya acquired 5,870 shares of Common Stock in the form of Restricted Stock Units (RSUs) at a price of $0.
• Director Anula Jayasuriya also acquired 5,870 Stock Options with an exercise price of $1.44.
• Both the RSU and option grants were approved by the issuer's board of directors on December 11, 2025, and were granted pursuant to the company's 2014 Stock Incentive Plan.
• The Restricted Stock Units (RSUs) are scheduled to vest on December 11, 2026.
• The Stock Options will vest ratably on a monthly basis over 12 months from the grant date, contingent on continued service on the board of directors.
• The company effected a 60-for-1 reverse stock split on May 23, 2024.
• The company effected a 25-for-1 reverse stock split on March 24, 2025.

Sentiment

Score: 7

Explanation: The filing reports a routine equity grant to a director, which is generally a positive event as it aligns management's interests with shareholders. The background information on reverse stock splits, while potentially negative for the company's overall health, is not directly tied to the sentiment of this specific compensation transaction.

Positives

• The equity grants align the director's financial interests with those of the shareholders, incentivizing long-term performance.
• The grants are part of a standard compensation plan, indicating ongoing commitment to executive and director incentives.

Future Outlook

The restricted stock units are set to vest on December 11, 2026. The stock options will vest ratably on a monthly basis over 12 months from the grant date, provided the reporting person continues to serve on the board of directors.

Industry Context

Equity grants to directors are a common practice in publicly traded companies to align the interests of board members with shareholders. The occurrence of two reverse stock splits (60-for-1 in 2024 and 25-for-1 in 2025) suggests the company has faced challenges maintaining its share price, a common issue for smaller biotechnology or pharmaceutical firms, often done to meet exchange listing requirements.

Comparison to Industry Standards

• Equity compensation for directors, including restricted stock units and stock options, is a standard practice across industries, particularly in the biotechnology sector, to attract and retain talent and align interests.
• The specific value and vesting schedule of these grants would typically be benchmarked against peer companies of similar size and stage within the pharmaceutical or biotech industry, though such comparative data is not provided in this filing.
• Reverse stock splits, such as the 60-for-1 and 25-for-1 splits executed by Jaguar Health, are not an industry standard for healthy companies but are a common tactic employed by companies with persistently low share prices to increase their stock price and avoid delisting from major exchanges.

Corporate Governance

Related Party Transactions

• The acquisition of common stock and stock options by Director Anula Jayasuriya from Jaguar Health, Inc. constitutes a related party transaction, as it involves a company insider receiving compensation from the issuer.

Stakeholder Impact

• Shareholders: The grants align the director's interests with shareholders, potentially leading to better long-term decision-making. There is a minor dilutive effect from the issuance of new shares/options.
• Employees: No direct impact on employees is mentioned in this filing, but the 2014 Stock Incentive Plan may also apply to other employees.

Next Steps

• Vesting of Restricted Stock Units on December 11, 2026.
• Monthly vesting of Stock Options over 12 months, contingent on continued board service.

Key Dates

Keywords

Jaguar Health, JAGX, Form 4, Insider Transaction, Equity Grant, Stock Option, Restricted Stock Unit, Director Compensation, Reverse Stock Split